Using plasma exchange to successfully manage thyrotoxicosis in a patient with possible antithyroid drug-related thrombotic thrombocytopenic purpura

George JN, Cuker A. Drug-induced thrombotic microangiopathy. In: UpToDate (Eds. Leung LLK, Tirnauer JS), Wolters Kluwer. www.uptodate.com/contents/drug-induced-thrombotic-microangiopathy. (Accessed on September 14, 2016.)Search in Google Scholar

Kulaksizoglu M, Gonen MS, Kebapcilar L, Sahin F, Acikgoz B, Demir T, Dincturk E. Multiorgan dysfunction accompanied with metimazole and thyroid storm. Transfus Apher Sci 46, 149–152, 2012.10.1016/j.transci.2012.01.00122284265Search in Google Scholar

Mariotte E, Veyradier A. Thrombotic thrombocytopenic purpura: from diagnosis to therapy. Curr Opin Crit Care 21, 593–601, 2015.10.1097/MCC.000000000000025526418759Search in Google Scholar

Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30, 239–245, 1981.10.1038/clpt.1981.1547249508Search in Google Scholar

Papi G, Corsello SM, Pontecorvi A. Clinical concepts on thyroid emergencies. Front Endocrinol (Lausanne) 5, 102, 2014.10.3389/fendo.2014.00102407679325071718Search in Google Scholar

Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees S, Samuels M, Sosa JA, Stan MN, Walter M. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis. Thyroid 26, 1343–1421, 2016.Search in Google Scholar

Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, Szczepiokowski ZM, Williams ME, Wu Y, Shaz BH. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 28, 145–284, 2013.10.1002/jca.2127623868759Search in Google Scholar